Epithalon
5–10 mg · Daily for 10-day cycle
Evidence
- Human Studies
- 5
- Animal Studies
- 30
- Clinical Status
- Research
- Confidence
- Low
- Long-Term Safety
- Unknown outside a narrow set of Russian institutional studies
What this score is: a measure of how much research exists and how far along it is (animal-only vs. human trials, research-stage vs. FDA approved) — not how safe, effective, or worth trying a compound is. A low score usually means “early stage” or “understudied,” not “bad.” A high score doesn’t mean “better” for your goals than a lower-scored one.
This is not my personal rating of the compound, not a recommendation, and not medical advice. It’s a general research synthesis for informational purposes only, not a live literature count. See the linked research and talk to a licensed clinician before making decisions based on it.
Mechanism
A synthetic tetrapeptide studied primarily by a small number of affiliated Russian research groups (Khavinson et al.) for potential telomerase activation and pineal gland regulation. The "anti-aging" literature has not been independently replicated at scale outside those institutions.
Common Protocols
- 5–10 mg daily for a 10–20 day cycle, subcutaneous, per the Russian research protocols this is based on; typically limited to 1–2 cycles per year in that literature
Side Effects
- Injection site irritation
- No systematic independent safety data
Interactions
- No formal interaction data exists
Practical Details
- Cost
- $$
- Typical Vial Size
- 10 mg
- Storage
- Refrigerate after reconstitution
Research Links
Telomere elongation, anti-aging